ide links}
Epidemiology
1. www.who.int/vaccines/en/pertussis.shtml
2. www.immunize.org/images/ca.d/iped1861/img0007.htm
3. www.whale.to/vaccines/whooping 3.html
4. Pertussis. World Health Organization. 3/22/2004
5. www.pertussis.com/digest/index.html#intro
6. www.pertussis.com/repguide.html
7. www.doh.wa.gov/topics/pertussis.htm
8. www.pertussis.com/digest/press_030503.html
9. Cherry, James D. “The Science and Fiction of ‘Resurgence' of Pertussis.” Pediatrics . 2003 August; 112 (2): 405-6.
10. www.kidsource.com/kidsource/content/news/infant_vaccines8_1_96.html
Infection
1. Galazka, Artur. Immunological Basis for Immunization Series Module 4: Pertussis. World Health Organization 3/20/2004
2. Immunization, Vaccines and Biologicals. World Health Organization: http://www.who.int/vaccines/en/pertussis.shtml. 3/24/2004
3. Pertussis. World Health Organization. 3/22/2004
4. Pertussis: Disease Overview. Pertussis.com: http://www.pertussis.com/backgrounder.html 3/24/2004
5. Todar, Kenneth. Bordetella pertussis and Whooping Cough. University of Wisconsin-Madison Department of Bacteriology. http://textbookofbacteriology.net/pertussis.html . 3/24/2004
Microbiology
1. Ausiello CM, Lande R, Stefanelli P, Fazio C, Fedele G, Palazzo R, Urbani F, Mastrantonio P.. Clin Diagn Lab Immunol. 2003 Jul;10(4):637-42. T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.
2. Mattoo S, Foreman-Wykert AK, Cotter PA, Miller JF. Front Biosci. 2001 Nov 1;6:E168-86. Mechanisms of Bordetella pathogenesis.
3. Carter CR, Dagg BM, Whitmore KM, Keeble JR, Asokanathan C, Xing D, Walker KB. Cell Immunol. 2004 Jan;227(1):51-8. The effect of pertussis whole cell and acellular vaccines on pulmonary immunology in an aerosol challenge model.
4. Sawyer GW, Ehlert FJ. J Pharmacol Exp Ther. 1999 Apr;289(1):464-76. Muscarinic M3 receptor inactivation reveals a pertussis toxin-sensitive contractile response in the guinea pig colon: evidence for M2/M3 receptor interactions.
5. Hirano T, Kawasaki N, Miyataka H, Satoh T. Biol Pharm Bull. 2001 Aug;24(8):962-3. Wistar strain rats as the model for IgE antibody experiments.
6. van den Akker WM. Microbiology. 1998 Jun;144 ( Pt 6):1527-35. Lipopolysaccharide expression within the genus Bordetella: influence of temperature and phase variation.
7. Deora R, Bootsma HJ, Miller JF, Cotter PA. Mol Microbiol. 2001 May;40(3):669-83. Diversity in the Bordetella virulence regulon: transcriptional control of a Bvg-intermediate phase gene.
Vaccines
1. www.niaid.nih.gov/publications/discovery/pertus.htm
2. www.who.int/vaccines/en/pertussis.shtml#whole
3. J.D. Cherry, Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials. Pediatr Infect Dis J 16 (1997), p S90-S96.
4. Geier DA, Geier MR, Serious neurological conditions following pertussis immunization: an analysis of endotoxin levels, the vaccine adverse events reporting system (VAERS) database and literature review. Pediatr Rehabil. 2002 Jul-Sept; 5 (3): 177-82. Review.
5. von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis. 2002 Dec;2(12):744-50. Review.
6. John Fontanesi, Michelle De Guire, David Kopald and Kathy Holcomb, The price of prevention: Cost of recommended activities to improve immunizations. American Journal of Preventive Medicine. Volume 26, Issue 1, January 2004, Pages 41-45.
7. Madsen T. Whooping cough: its bacteriology, diagnosis, prevention, and treatment. Boston Medical Surgical Journal 1925. 192(2):50-60.
8. Patrick Olin, Lennart Gustafsson, Luis Barreto, Luc Hessel, T. Christopher Mast, Annelies Van Rie, Hugues Bogaerts and Jann Storsaeter. Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine. Volume 21, Issues 17-18, 16 May 2003, Pages 2015-2021.
9. Yeh S. Pertussis: persistent pathogen, imperfect vaccines. Expert Rev Vaccines. 2003 Feb;2(1):113-27. Review.
10. www.fda.gov/cber/vaccine/licvacc.htm
11. Weingart CL, Mobberly-Shumann PS, Hewlett El, Gray Mc, Weiss AA. Neutralizing antibodies to adenyl cyclase toxin promote phagocytosis of Bordella pertussis by human neutrophils. Infect. Immun. 68, 7152-7155(2000)
12. www.who/int/vaccines/en/diptheris.shtml
13. www.cdc.gov/nip/publications/pink
14. Crowcroft , N.S. , et al. How best to estimate the global burden of pertussis? Lancet Infect Dis, 2003. 3 (7): p. 413-8.
15. Van Damme, P. and M. Burgess. Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults. Vaccine, 2004. 22 (3-4): p. 305-8.
16. Jefferson, T., M. Rudin, and C. Di Pietrantonj. Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence. Lancet Infect Dis, 2004. 4 (2): p. 84-90.
17 Ausiello, C.M., et al., Native and genetically inactivated pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses. J Infect Dis, 2002. 186 (3): p. 351-60.
18. Carter, C.R.D., et al., The effect of pertussis whole cell and acellular vaccines on pulmonary immunology in an aerosol challenge model. Cellular Immunology, 2004. 227 (1): p. 51-58.
19. Del Giudice, G. and R. Rappuoli, Genetically derived toxoids for use as vaccines and adjuvants. Vaccine, 1999. 17 (Supplement 2): p. S44-S52.
20. Kirimanjeswara, G.S., P.B. Mann, and E.T. Harvill, Role of Antibodies in Immunity to Bordetella Infections. Infect. Immun., 2003. 71 (4): p. 1719-1724.
21. Mills, K.H.G., et al., A Murine Model in Which Protection Correlates with Pertussis Vaccine Efficacy in Children Reveals Complementary Roles for Humoral and Cell-Mediated Immunity in Protection against Bordetella pertussis. Infect. Immun., 1998. 66 (2): p. 594-602.
22. Greco, D., et al., A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med, 1996. 334 (6): p. 341-8.
23. Geier, M and Geier, D. Neurodevelopmental Disorders after Thimerosal-Containing Vaccines: A Brief Communication. Experimental Biology and Medicine. 228: 660-664 (2003).